Cyclacel Pharmaceuticals Inc. (CYCC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Cyclacel Pharmaceuticals ...

NASDAQ: CYCC · Real-Time Price · USD
6.37
-0.40 (-5.91%)
At close: Sep 11, 2025, 3:59 PM

Cyclacel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
4.28K 3.45M 3.14M 2.98M 6M 2.8M 3.38M 5.94M 10.16M 11.44M 18.34M 23.71M 29.08M 29.64M 36.56M 40.22M 43.64M 47.78M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash & Short-Term Investments
4.28K 3.45M 3.14M 2.98M 6M 2.8M 3.38M 5.94M 10.16M 11.44M 18.34M 23.71M 29.08M 29.64M 36.56M 40.22M 43.64M 47.78M
Receivables
50K n/a 237K 1.62M 974K 1.34M 2.93M 2.53M 1.95M 6.12M 4.66M 2.79M 2M 6.03M 3.73M 2.51M 1.59M 2.14M
Accounts Receivables
50K n/a 237K 1.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Receivables
n/a n/a n/a n/a 974K 1.34M 2.93M 2.53M 1.95M 6.12M 4.66M 2.79M 2M 6.03M 3.73M 2.51M 1.59M 2.14M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 577K -2.51M 836K -2.01M
Prepaid Expenses
n/a 70K n/a n/a 433K 329K 792K 692K 991K 827K 976K 1.25M 921K 667K 577K 530K 836K 448K
Other Current Assets
-49.89K 194K 300K 309K 300K 365K 341K 1.95M 2.19M 595K 426K 170K 79K 239K -498K 2.63M -694K 2.11M
Total Current Assets
4.38K 3.71M 3.67M 4.91M 7.71M 4.83M 7.44M 11.11M 15.29M 18.97M 24.41M 27.91M 32.08M 36.58M 40.94M 43.38M 46.2M 50.46M
Property-Plant & Equipment
18.00 20K 7K 55K 70K 86K 102K 125K 148K 170K 174K 190K 209K 72K 94K 115K 131K 1.35M
Goodwill
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Intangible Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Tax Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 412K 413K 413K 1.24M 1.26M 1.26M 1M 2.92M 2.92M 2.92M 3.06M 2.98M 1.55M 1.51M n/a n/a
Total Long-Term Assets
18.00 20K 419K 468K 483K 1.33M 1.36M 1.38M 1.15M 3.09M 3.09M 3.11M 3.27M 3.05M 1.65M 1.62M 131K 1.35M
Other Assets
n/a n/a 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Assets
4.4K 3.73M 4.09M 5.38M 8.19M 6.17M 8.8M 12.5M 16.44M 22.06M 28.05M 31.02M 35.35M 39.63M 42.59M 45M 46.33M 51.82M
Total Payables
221K 114K 4.6M 4.13M 4.74M 5.2M 3.54M 1.57M 2.17M 2.51M 2.56M 983K 2.21M 2.85M 2.12M 1.51M 1.2M 871K
Account Payables
221K 114K 4.6M 4.13M 4.74M 5.2M 3.54M 1.57M 2.17M 2.51M 2.56M 983K 2.21M 2.85M 2.12M 1.51M 1.2M 871K
Other Payables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Accrued Expenses
n/a 532K 1.39M 1.89M 2.05M 2.85M 4.24M 6.22M 4.34M 4.61M 4.62M 3.2M 2.26M 3.24M 2.54M 1.95M 1.66M 1.5M
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Current Capital Lease Obligations
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Tax Payables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
-220.24K 17K 283K 332K 395K 296K 380K 356K 234K 223K 326K 172K 558K 118K 753K 125K 264K 398K
Total Current Liabilities
760.00 663K 6.27M 6.35M 7.19M 8.35M 8.16M 8.15M 6.75M 7.34M 7.51M 4.35M 5.03M 6.2M 5.41M 3.59M 3.12M 2.77M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Non-Current Capital Lease Obligations
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Non-Current Deferred Revenue
10K 9K n/a n/a 5K 21K 37K 52K 66K 80K 106K 107K 113K 15K 30K 44K n/a 996K
Non-Current Deferred Tax Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
10.00 9K n/a n/a 5K 21K 37K 52K 66K 80K 106K 107K 113K 15K 30K 44K n/a 996K
Other Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Capital Lease Obligations
10K 9K n/a n/a 5K 21K 37K 52K 66K 80K 106K 107K 113K 15K 30K 44K n/a 996K
Total Liabilities
770.00 672K 6.27M 6.35M 7.19M 8.37M 8.2M 8.2M 6.81M 7.42M 7.62M 4.46M 5.14M 6.22M 5.44M 3.63M 3.12M 3.77M
Treasury Stock
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Preferred Stock
3.00 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
2K 204K 9K 2K 2K 1K 1K 12K 4.5M 4.5M 1K 4.5M 11K 10K 10K 10K 9K 9K
Retained Earnings
-441.78K -440.46M -439.49M -436.44M -434.49M -431.23M -428.28M -423.01M -417.41M -411.96M -405.73M -398.74M -393.64M -389.07M -384.53M -379.66M -374.68M -369.55M
Additional Paid-In Capital
445.4M 443.32M 438.2M 436.5M 436.4M 429.92M 429.8M 428.46M 423.63M 423.32M 422.98M 422.54M 425.11M 423.29M 422.96M 421.77M 418.54M 418.32M
Comprehensive Income
n/a 1K -891K -1.03M -915K -898K -908K -1.17M -1.1M -1.22M -1.32M -1.75M -1.28M -823K -748K -753K -658K -730K
Other Stockholders Equity
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
3.63K 3.06M -2.17M -970K 999K -2.21M 607K 4.3M 9.63M 14.64M 20.43M 26.56M 30.21M 33.41M 37.69M 41.36M 43.22M 48.05M
Total Equity
3.63K 3.06M -2.17M -970K 999K -2.21M 607K 4.3M 9.63M 14.64M 20.43M 26.56M 30.21M 33.41M 37.26M 41.36M 43.22M 48.05M
Minority Interest
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Liabilities & Equity
4.4K 3.73M 4.09M 5.38M 8.19M 6.17M 8.8M 12.5M 16.44M 22.06M 27.5M 31.02M 35.35M 39.63M 42.59M 45M 46.33M 51.82M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Debt
10K 9K n/a n/a 5K 21K 37K 52K 66K 80K 106K 107K 113K 15K 30K 44K n/a 996K
Net Debt
-4.28K -3.44M -3.14M -2.98M -6M -2.78M -3.34M -5.89M -10.1M -11.36M -18.24M -23.6M -28.96M -29.62M -36.53M -40.17M -43.64M -46.78M
Book Value
3.63K 3.06M -2.17M -970K 999K -2.21M 607K 4.3M 9.63M 14.64M 20.43M 26.56M 30.21M 33.41M 37.14M 41.36M 43.22M 48.05M
Book Value Per Share
0.00 236.28 -0.25 -0.48 0.59 -1.81 0.71 5.10 11.51 17.51 24.44 32.35 44.70 50.15 56.62 66.23 70.20 101.53
Source: Financial Modeling Prep. Financial Sources.
SEC Filings: 10-K · 10-Q